Bacterial

Items 551-600 of 1393

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Bacterial Biofilm Formation Inhibitor

    Ethyl acetoacetate is an ester compound that acts as an inhibitor of bacterial biofilm formation. Its unique chemical structure facilitates its role in impairing the ability of bacteria to adhere and form protective biofilms, making it a valuable research tool in studying microbial resistance and infection control. This reagent is useful in various biological applications, particularly in investigations aimed at understanding bacterial behavior and developing new antimicrobial strategies.
  2. Antibacterial Agent

    Colistin methanesulfonate sodium salt is an antibacterial agent that primarily targets Gram-negative bacteria, including Pseudomonas aeruginosa. It demonstrates minimum inhibitory concentration (MIC) values ranging from 4 to 16 mg/L against susceptible strains, making it an essential compound for research in antimicrobial resistance and the efficacy of antibiotic treatments. This reagent is suitable for studies requiring a focus on antibiotic susceptibility and the mechanisms of action of colistin derivatives.
  3. Antibacterial Agent

    Pectin is a heteropolysaccharide primarily derived from the cell walls of higher plants, functioning as an effective antibacterial agent. It exhibits broad-spectrum antimicrobial activity, binding to bacterial toxins and irritants in the intestinal mucosa, thereby alleviating mucosal irritation. Additionally, pectin serves as a versatile agent for the formation of nanoparticles, facilitating the delivery of therapeutic compounds. Its properties make it valuable for research in gastrointestinal health and drug delivery systems.
  4. Antibacterial Agent

    Ceftolozane is a cephalosporin antibiotic that specifically targets bacterial infections by inhibiting cell wall synthesis. It exhibits potent antibacterial activity against Pseudomonas aeruginosa and various Enterobacteriaceae strains, with minimal inhibitory concentrations (MICs) reported at 0.5 mg/L and 0.25-0.5 mg/L, respectively. This reagent is valuable for research applications focused on antibiotic resistance and the development of new therapeutic strategies.
  5. Antibacterial Agent

    Thiocarlide is an effective antibacterial agent primarily targeting Mycobacterium species. It demonstrates significant inhibitory activity against Mycobacterium tuberculosis H37Rv, Mycobacterium bovis BCG, Mycobacterium avium, and Mycobacterium aurum A+, with minimum inhibitory concentrations (MICs) of 2.5, 0.5, 2.0, and 2.0 μg/mL, respectively. Thiocarlide can be utilized in research applications focused on tuberculosis and other mycobacterial infections.
  6. Antibacterial Agent

    Cyclacillin is an orally active aminopenicillin antibiotic that primarily targets bacterial cell wall synthesis. It exhibits significant antibacterial activity against a broad spectrum of gram-positive and gram-negative pathogens. This compound is useful in research applications focused on infection models and the study of antibiotic resistance mechanisms.
  7. Antibacterial Agent

    Tellimagrandin II is an antibacterial agent that disrupts the integrity of the cell wall in Staphylococcus aureus, leading to cell lysis and loss of cytoplasmic contents. Additionally, it demonstrates anti-inflammatory properties and inhibits acetylcholinesterase (AChE), which may contribute to improvements in memory impairment. This compound is of interest in research focusing on antibacterial strategies, inflammatory pathways, and neurodegenerative conditions.
  8. Bacterial Inhibitor

    Flomoxef sodium is an oxacephem antibiotic that primarily targets bacterial ribosomes, inhibiting protein synthesis. It exhibits potent activity against a range of Gram-positive bacteria, making it suitable for research in antimicrobial resistance and bacterial infections. Flomoxef sodium can be utilized in studies exploring antibiotic efficacy and drug resistance mechanisms.
  9. Bacterial Inhibitor

    Virginiamycin S1 is a cyclic hexadepsipeptide antibiotic that inhibits bacterial protein synthesis by targeting aminoacyl-tRNA binding and peptide bond formation. As a type B compound in the streptogramin family, it exhibits potent bactericidal activity against a diverse array of Gram-positive bacteria. Virginiamycin S1, particularly in combination with virginiamycin M1, is valuable in research focused on overcoming multidrug-resistant bacterial infections. Its application is relevant in fields such as microbiology and pharmacology, particularly in the study of antibiotic efficacy and resistance mechanisms.
  10. Antibacterial Agent

    Rosoxacin is an orally active broad-spectrum antibacterial quinolone antibiotic that primarily targets Gram-negative bacteria. It demonstrates effective inhibition against Neisseria gonorrhoeae, with a minimum inhibitory concentration (MIC) range of 0.03-0.125 µg/mL. This compound is valuable in research related to urinary tract infections and various sexually transmitted diseases, providing insights into bacterial resistance and treatment efficacy.
  11. Antibacterial Agent

    Targocil-II is an ABC transporter inhibitor demonstrating an IC50 value of 137 nM. By binding to allosteric sites within the transmembrane domain, Targocil-II effectively prevents ATP hydrolysis. This compound exhibits antibacterial activity, making it a valuable tool for research focused on combating multidrug resistance in bacterial pathogens.
  12. Antibacterial Agent

    CRS3123 dihydrochloride is a synthetic antibacterial agent that effectively targets methionyl-tRNA synthetase (MetRS) in Clostridioides difficile. By inhibiting MetRS, CRS3123 dihydrochloride reduces toxin production and spore formation associated with Clostridioides difficile infections (CDI). This compound serves as a valuable tool for research into CDI and potential therapeutic strategies.
  13. Antibacterial Agent

    Temafloxacin is an orally active quinolone antibiotic that exhibits broad-spectrum antibacterial activity. Primarily utilized for the treatment of lower respiratory and genitourinary tract infections, Temafloxacin demonstrates favorable tolerability in patients. Its efficacy in combating various bacterial pathogens makes it a valuable tool in microbiological research and infection control studies.
  14. Antibacterial Agent

    Cefpiramide is a semisynthetic cephalosporin antibiotic targeting bacterial cell wall synthesis. It exhibits broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria, making it valuable for combating various bacterial infections. Cefpiramide is also moderately susceptible to β-lactamase, which is relevant in resistance studies and the evaluation of antibacterial efficacy. This reagent is suited for research applications in microbiology and antibiotic resistance.
  15. Bacterial Inhibitor

    PNU-105368 is an antibacterial compound that serves as a metabolite of linezolid. It demonstrates efficacy in inhibiting bacterial growth and is primarily excreted via the kidneys and feces. This compound is relevant for research focusing on bacterial resistance and the pharmacokinetics of oxazolidinones.
  16. Bacterial Inhibitor

    Sisomicin is a broad-spectrum aminoglycoside antibiotic that targets bacterial ribosomes, inhibiting protein synthesis. It exhibits potent activity against Gram-positive bacteria, making it valuable in microbiological research. Sisomicin is commonly used in studies investigating bacterial resistance mechanisms and in the evaluation of antibacterial efficacy.
  17. Bacterial Inhibitor

    Thiamphenicol-d3 is a deuterium-labeled variant of the broad-spectrum antibiotic Thiamphenicol, which targets the 50S ribosomal subunit. By binding to this subunit, it inhibits protein synthesis, exhibiting bacteriostatic activity against a wide range of Gram-negative and Gram-positive aerobic and anaerobic bacteria. This reagent is valuable for research applications involving microbiology and the study of antibiotic mechanisms.
  18. Bacterial Inhibitor

    2,2':5',2''-Terthiophene is a heterocyclic oligomer that primarily targets bacterial inhibition. This compound exhibits significant antimicrobial activity, making it a valuable tool for studying bacterial growth and resistance mechanisms. Additionally, 2,2':5',2''-Terthiophene serves as an essential building block in the synthesis of organic semiconductor materials, particularly polythiophene, which has applications in electronic devices and sensors.
  19. Antibacterial agent

    Lascufloxacin is a potent fluoroquinolone antibacterial agent that effectively targets bacterial DNA gyrase and topoisomerase IV, leading to DNA replication inhibition. It demonstrates significant activity against a range of pathogens, including strains resistant to traditional quinolone therapies. Lascufloxacin is primarily applicable in the treatment of various infectious diseases, particularly lower respiratory tract infections.
  20. Bacterial Inhibitor

    Moxifloxacin hydrochloride monohydrate is a potent bacterial inhibitor that targets DNA gyrase and topoisomerase IV, leading to the disruption of bacterial DNA replication and transcription. It exhibits strong efficacy against Streptococcus pneumoniae and is primarily utilized in the study of bacterial infections, including research on tuberculosis. Its oral bioavailability and broad-spectrum activity make it a valuable reagent for microbiological studies and antibiotic efficacy testing.
  21. Bacterial Inhibitor

    Helvolic acid, also known as Fumigacin, is a natural antibiotic derived from Xylaria sp. It exhibits potent activity against Gram-positive bacteria, making it a valuable tool for investigating bacterial inhibition. This compound can be utilized in microbiological studies to explore mechanisms of antibiotic action and resistance.
  22. Antibacterial Agent

    SABA1 is an antibacterial agent that exhibits significant activity against Pseudomonas aeruginosa and Escherichia coli. With an IC50 of 4.0 µM against E. coli ACC, SABA1 is a valuable tool for researching bacterial infections and antimicrobial resistance in various biological studies.
  23. Antibacterial Agent

    Mafenide is a sulfonamide-type antimicrobial agent that primarily targets bacterial nucleotide synthesis. It exhibits potent antibacterial activity against a broad spectrum of pathogens, including both Gram-positive and Gram-negative bacteria, such as Pseudomonas aeruginosa. Mafenide is commonly utilized in research related to wound healing and the treatment of burn injuries, due to its effective antimicrobial properties.
  24. Antibacterial Agent

    Gepotidacin mesylate hydrate is an orally active antibiotic that functions as a bacterial type II topoisomerase inhibitor. It interferes with bacterial DNA replication by obstructing topoisomerase enzymes, specifically targeting topoisomerase IV and the B subunit of DNA gyrase. This compound is primarily used in research applications investigating antibacterial mechanisms and the development of novel antimicrobial agents.
  25. Bacterial Inhibitor

    Cefamandole is a semi-synthetic second-generation cephalosporin antibiotic that functions as a bacterial inhibitor by disrupting cell wall synthesis. It exhibits broad-spectrum antimicrobial activity against various Gram-positive cocci and several Gram-negative bacilli, while maintaining resistance to hydrolysis by certain β-lactamases. Although effective in many contexts, it shows limited efficacy against species such as Pseudomonas, Proteus vulgaris, and Providencia stuartii. Cefamandole is primarily excreted in the urine in its active form and is utilized in research applications focused on bacterial infections, although its penetration across the blood-brain barrier is minimal.
  26. Antibacterial Agent

    Sulfamonomethoxine sodium is a long-acting sulfonamide antibacterial agent that inhibits dihydropteroate synthase, thereby blocking folic acid synthesis. Its antibacterial properties make it useful in various applications, including blood kinetic studies and research focused on microbial resistance mechanisms. This compound is valuable for scientists investigating the effects of folate metabolism and the therapeutic potential of sulfonamides.
  27. Bacterial Inhibitor

    Cinnamycin is a tetracyclic peptide antibiotic that specifically targets phosphatidylethanolamine (PE). Its primary mechanism involves disrupting bacterial membrane integrity, leading to inhibition of growth in Gram-positive bacteria. Cinnamycin is commonly utilized in microbiological research to study antibiotic resistance and bacterial membrane dynamics.
  28. Antibacterial Agent

    Pisiferic acid is an antibacterial agent that exhibits inhibitory activity against both Gram-negative and Gram-positive bacteria, including Proteus vulgaris, Staphylococcus aureus, and Bacillus subtilis. It serves as a valuable tool for research on bacterial infections, allowing for the exploration of mechanisms of antibacterial resistance and the development of new therapeutic strategies.
  29. Antibacterial Agent

    Dup-721 is an orally active broad-spectrum antibacterial agent that exhibits significant efficacy against a range of both clinically susceptible and resistant bacterial strains, with particular activity against Mycobacterium tuberculosis. This compound is valuable for research applications aimed at understanding bacterial resistance mechanisms and developing novel therapeutic strategies for tuberculosis and other bacterial infections.
  30. Bacterial Inhibitor

    Aureothricin is a dithiolopyrrolone (DTP) antibiotic with a primary mechanism of inhibiting bacterial growth. It demonstrates broad-spectrum antibiotic activity and has the ability to impede the adhesion of human umbilical vein endothelial cells (HUVECs) to vitronectin. This compound is valuable for research applications focused on bacterial inhibition and the modulation of cell adhesion processes.
  31. Bacterial Inhibitor

    Flomoxef is an oxacephem antibiotic that exerts its bactericidal effects primarily by inhibiting bacterial cell wall synthesis. It demonstrates significant activity against a range of Gram-positive bacteria. This compound is utilized in research settings to investigate antibiotic resistance mechanisms and to develop novel antibacterial agents.
  32. Bacterial Inhibitor

    Flucloxacillin is a β-lactam antibiotic that primarily targets bacterial cell wall synthesis by inhibiting transpeptidation enzymes. It exhibits potent antibacterial activity against a variety of gram-positive and some gram-negative bacteria, making it valuable in treating infections caused by staphylococci and streptococci. This reagent is widely utilized in microbiological studies and antibiotic susceptibility testing to evaluate bacterial resistance.
  33. Antibacterial Peptide

    D2A21 is an antibacterial peptide derived from cecropins that exhibits potent antimicrobial activity. It has a minimum cidal concentration of 21.69 μg/mL against Chlamydia trachomatis, demonstrating its effectiveness in combating bacterial infections. This peptide is valuable for research applications aimed at developing novel antimicrobial therapies and studying bacterial resistance mechanisms.
  34. Bacterial Inhibitor

    Sulfadimethoxine-d6 is a deuterated form of Sulfadimethoxine, a sulfonamide antibiotic that acts as a bacterial inhibitor by interfering with folate synthesis in pathogenic microorganisms. This reagent is primarily utilized in pharmacokinetics and metabolic studies, allowing for improved tracking of the compound in biological systems. Its deuterium labeling enhances analytical sensitivity in various applications, including drug metabolism research and isolation studies.
  35. Antibacterial Agent

    Avilamycin C is an avilamycin-type antibiotic that targets bacterial cell wall synthesis. It exhibits potent antibacterial activity, particularly against Gram-positive bacteria, making it valuable in research focused on antibiotic resistance and bacterial infections. This compound serves as a crucial tool for studies investigating mechanisms of action and the development of novel antibacterial therapies.
  36. Bacterial Inhibitor

    Bacampicillin is a penicillin antibiotic that serves as a prodrug of ampicillin, designed to enhance oral bioavailability. It exerts its antibacterial activity through the inhibition of cell wall synthesis in susceptible bacteria. This compound is utilized primarily in microbiological research and studies targeting bacterial infections.
  37. Bacterial Metabolite

    Palmitoyl serinol is a bacterial metabolite analog of the endocannabinoid N-palmitoyl ethanolamine (PEA). It exhibits enhanced activity in improving the epidermal permeability barrier, demonstrating efficacy in both normal and inflamed skin conditions. Its unique properties make it a valuable tool for research into skin barrier function and inflammation-related studies.
  38. Non-Antibacterial Macrolide Agent

    Glasmacinal is a non-antibacterial macrolide agent that primarily targets inflammatory pathways. It exhibits significant anti-inflammatory activity, making it a valuable tool for researchers studying inflammation-related processes. This compound can be utilized in various biological research applications, including the exploration of immune response modulation and the development of novel therapeutic strategies.
  39. Anti-Bacterial Agent

    Pacidamycin 7 is an anti-bacterial agent primarily targeting Pseudomonas aeruginosa. This compound exhibits inhibitory effects on various bacterial strains, including suppurative Staphylococcus and Escherichia coli. Notably, serum and pH levels can modulate its antibacterial effectiveness, making it relevant for studies focused on resistance mechanisms and antibiotic development.
  40. Anti-Bacterial Agent

    Kibdelin C1 is a potent anti-bacterial agent that exhibits activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It demonstrates similar efficacy to Vancomycin, making it a valuable compound for research aimed at combating resistant bacterial strains. Its unique mechanism offers potential applications in the development of new therapeutic strategies against resistant infections.
  41. Anti-Bacterial Agent

    4"-Demethylgentamicin C1a acts as an anti-bacterial agent with significant efficacy against both Gram-positive and Gram-negative bacteria. Its mechanism involves inhibition of bacterial protein synthesis, making it a valuable tool in studies related to bacterial infections. This compound is relevant for research applications in microbiology and drug development, particularly for understanding antibiotic resistance and enhancing therapeutic strategies.
  42. Anti-Bacterial Agent

    Oganomycin B is an antibacterial agent exhibiting pronounced stability compared to cephalosporin and demonstrating resistance to both Gram-positive and Gram-negative bacteria. Its efficacy is particularly notable in combating Gram-negative bacterial strains, making it a valuable tool for research into antibacterial treatments and mechanisms of resistance.
  43. Antibacterial Agent

    KP 736 sodium is a broad-spectrum antibacterial agent that targets bacterial cell integrity. It demonstrates significant in vitro activity against Gram-negative bacteria, particularly Pseudomonas aeruginosa and other multidrug-resistant strains. This compound is valuable for research focused on bacterial infections and the development of novel antibacterial therapies.
  44. Anti-Bacterial Agent

    Formadicin C is an anti-bacterial agent with notable effectiveness against various strains of Pseudomonas, Proteus, and alkali-producing bacilli. Its potent activity makes it a valuable compound for research focused on combating bacterial infections and understanding microbial resistance mechanisms. Researchers may utilize Formadicin C in studies pertaining to antibiotic efficacy and the development of new antimicrobial therapies.
  45. Anti-Bacterial Agent

    Enaminomycin B is an anti-bacterial agent that exhibits activity against both Gram-positive and Gram-negative bacteria. This compound acts by disrupting bacterial cell wall synthesis, contributing to its potential as a therapeutic agent in combating bacterial infections. Enaminomycin B may be utilized in research applications focused on antibiotic resistance mechanisms and the development of new antibacterial strategies.
  46. Anti-Bacterial Agent

    Kinamycin A is an antibacterial agent primarily targeting mycobacterial infections. It exhibits notable effects against various bacteria, while demonstrating limited efficacy against Gram-negative strains. This compound is valuable for research applications focused on the development of treatments for bacterial infections, particularly those caused by mycobacteria.
  47. Anti-Bacterial Agent

    Quinomycin B is an anti-bacterial agent that exhibits potent activity against Gram-positive bacteria and is also effective against certain Gram-negative strains. Additionally, Quinomycin B demonstrates cytotoxic effects on HeLa cells, making it valuable in cancer research. This compound has also shown protective effects in mouse models inoculated with poliovirus, indicating potential applications in virology studies.
  48. Anti-Bacterial Agent

    Kirrothricin is an antibacterial agent that primarily exhibits efficacy against a range of Gram-positive bacteria. It is particularly valuable in research focused on combating bacterial infections, providing insights into its use as a potential therapeutic candidate. However, it shows no activity against Bacillus subtilis, Escherichia coli, or fungal species. This specificity makes Kirrothricin a useful tool for studying antibacterial mechanisms and developing targeted treatments.
  49. Anti-Bacterial Agent

    Cladospolide B is a natural compound derived from the fungal strain Cladosporium sp. FT-0012. It exhibits limited antibacterial activity, making it a potential candidate for further research into its mechanisms and applications in antimicrobial studies. This compound can be of interest for investigations focused on exploring novel antibacterial agents and their modes of action.
  50. Bacterial Inhibitor

    2-C-Methyl-D-erythritol 4-phosphate is an intermediate in the methylerythritol phosphate (MEP) pathway, primarily present in prokaryotes. This compound plays a crucial role as a precursor in the biosynthesis of isoprenoids and non-isoprenoids, including essential vitamins. Its unique presence in bacteria, coupled with its absence in humans, positions it as a promising target for the development of bacterium-specific therapeutic agents for infectious disease treatment.

Items 551-600 of 1393

Page
per page
Set Descending Direction